No products in the cart.
A combination tablet integrating the benefits of a DPP-4 inhibitor (Vildagliptin) with the first-line biguanide (Metformin). This formulation offers a convenient two-in-one approach to lower fasting and postprandial blood sugar levels. It is an excellent option for patients inadequately controlled on Metformin alone...
A combination tablet integrating the benefits of a DPP-4 inhibitor (Vildagliptin) with the first-line biguanide (Metformin). This formulation offers a convenient two-in-one approach to lower fasting and postprandial blood sugar levels. It is an excellent option for patients inadequately controlled on Metformin alone, providing enhanced efficacy with the added benefit of weight neutrality and a favorable side effect profile.
Gludase Plus 50/550mg is a combination anti-diabetic medication containing Vildagliptin 50mg and Metformin 550mg. This advanced dual-therapy formulation targets two major defects of Type 2 Diabetes — insulin resistance and insufficient insulin secretion.
Vildagliptin enhances the body’s natural insulin response by improving incretin activity, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Together, they provide comprehensive glycemic control and help patients achieve and maintain target HbA1c levels.
| Ingredient | Strength |
|---|---|
| Vildagliptin | 50 mg |
| Metformin | 550 mg |
Gludase Plus 50/550mg is prescribed for adults with Type 2 Diabetes Mellitus who require combination therapy for improved glycemic control when diet, exercise, or single-drug therapy is insufficient.
Take as directed by your healthcare professional. It is usually administered once or twice daily with meals to reduce gastrointestinal side effects. Routine monitoring of blood glucose levels is recommended.
Reliable Dual Therapy for Consistent Blood Sugar Control – Gludase Plus 50/550mg.
Your email address will not be published. Required fields are marked *
Please login to write review!
Looks like there are no reviews yet.
Take it to your cart